Gabriele Mauro, PhD (@agmauro) 's Twitter Profile
Gabriele Mauro, PhD

@agmauro

Assistant Professor, Department of Pediatrics, Division of Pediatric Cardiology @VCU

ID: 1219246376770572288

calendar_today20-01-2020 13:12:56

55 Tweet

41 Followers

57 Following

AntonioAbbate (@abbateantonio) 's Twitter Profile Photo

Proud moment. Six Italian research fellows, all brilliant. Lucky me. IL-1 blockade in cardiovascular disease: an appraisal ... across different ... paradigms pubmed.ncbi.nlm.nih.gov/37705370/ Aldo Bonaventura Francesco Moroni, MD Michele Golino Marco Del Buono Alessandra Vecchié Nicola Potere

JACC Journals (@jaccjournals) 's Twitter Profile Photo

The #GCOS2023 Basic and Translational Research Symposium in #CardioOnc is currently underway with #JACC EiC Dr. Valentin Fuster and #JACCCardioOnc EiC Dr. Bonnie Ky!

The #GCOS2023 Basic and Translational Research Symposium in #CardioOnc is currently underway with #JACC EiC Dr. Valentin Fuster and #JACCCardioOnc EiC Dr. Bonnie Ky!
International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

🎙️ Dr. Carver is not just sharing insights at #GCOS2023, but also setting the fashion trend! Elegance and expertise combined. #CardioOnc

🎙️ Dr. Carver is not just sharing insights at #GCOS2023, but also setting the fashion trend! Elegance and expertise combined. #CardioOnc
Gabriele Mauro, PhD (@agmauro) 's Twitter Profile Photo

A shout out to Fadi N Salloum, Carlo Gabriele Tocchetti and all authors for this wonderful state of the art review. Highly recommended reading! Catch up on the latest. #JCCCardioOnc #gcos2023

Aldo Bonaventura (@aldobonaventura) 's Twitter Profile Photo

📢#Colchicine 💊 in perspective following the CLEAR SYNERGY #trial: The "one-size-fits-all” concept to be re-evaluated across the #CAD 💓 spectrum. Read this piece by AntonioAbbate Brittany Weber Luca Liberale Nicola Potere Simon Kraler on 📰 Journal of Cardiovascular Pharmacology | journals.lww.com/cardiovascular…

📢#Colchicine 💊 in perspective following the CLEAR SYNERGY #trial: The "one-size-fits-all” concept to be re-evaluated across the #CAD 💓 spectrum.
Read this piece by <a href="/AbbateAntonio/">AntonioAbbate</a> <a href="/Bweber04/">Brittany Weber</a> <a href="/liberale_luca/">Luca Liberale</a> <a href="/NicolaPotereMD/">Nicola Potere</a> <a href="/KralerSimon/">Simon Kraler</a> on 📰 <a href="/JCVPOnline/">Journal of Cardiovascular Pharmacology</a> |
journals.lww.com/cardiovascular…
Salvatore Carbone, PhD, RDN, FHFSA, FASPEN (@totocarbone) 's Twitter Profile Photo

🚨Now Hiring: Postdoc Position! Join our cardiometabolic lab EVMS Medicine Old Dominion University for a 2-year postdoctoral fellowship! We’re especially interested in candidates with background in cardiometabolic health. Details here: nam11.safelinks.protection.outlook.com/?url=https%3A%… #PostDocJobs #cardiometabolic

Aldo Bonaventura (@aldobonaventura) 's Twitter Profile Photo

🚨 SGLT-2 inhibitors were found to improve clinical outcomes in patients with cardiac amyloidosis. Here, we provided some additional insights about the role of GDMTs in patients with #heartfailure and #cardiacamyloidosis. 🗒️ Open access at European Journal of Clinical Investigation : onlinelibrary.wiley.com/doi/10.1111/ec…

🚨 SGLT-2 inhibitors were found to improve clinical outcomes in patients with cardiac amyloidosis.
Here, we provided some additional insights about the role of GDMTs in patients with #heartfailure and #cardiacamyloidosis.
🗒️ Open access at <a href="/EJCI_News/">European Journal of Clinical Investigation</a> : onlinelibrary.wiley.com/doi/10.1111/ec…